About Us

Epigenic Therapeutics is a frontier biotechnology company dedicated to developing next-generation gene modulation therapy utilizing regulation of epigenetic genome for a variety of diseases. Founded in 2021 by leading scientists, Epigenic Therapeutics focused on discovering epigenetic engineering technologies and developing epigenetic therapies, the company has multiple pipeline projects, including treatment for metabolic, cardiovascular, viral hepatitis, ocular, oncology and rare diseases.

Pioneering Epigenetic Medicine

Epigenic Therapeutics’ EPIREG^®proprietary technology platform employs its own artificial intelligence (AI) algorithms to explore and obtain innovative CRISPR-Cas components to regulate target gene(s) expression without changing the DNA sequence. Combining a patented lipid nanoparticle (LNP) delivery system, our platform has been proven to precisely and efficiently deliver medicine to targeted cells and tissues in metabolic, cardiovascular, viral hepatitis, ocular, oncology and rare disease models.

Learn more

Our Culture

Vision

To commit to the development of safe and sustainable epigenetic therapy, help people improve the quality of life
Mission

To pioneer gene regulation-based biotherapeutics in order to benefit patients worldwide
Values

Respect to talents, revere for life, strive to excellence, and innovate for advancement